Although OSM has been proposed as a novel therapeutic target for metabolic syndrome, further research is warranted to provide insights into its role in inflammation, insulin resistance, and lipid metabolism in the context of obesity-related metabolic syndrome. This evidence concerns the gene OSM and metabolic syndrome.